Webinar: Best Practices for Antibody Specificity Testing for IND Submissions скачать в хорошем качестве

Webinar: Best Practices for Antibody Specificity Testing for IND Submissions

Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs. Recent studies show that up to one-third of antibody drugs display off-target binding—many of which go undetected by conventional TCR studies. So, what are the alternatives? Watch our webinar to learn about a better approach to specificity profiling using new, innovative cell-based protein arrays. We’ll take a deep dive into the Membrane Proteome Array (MPA), a 7,000-protein array platform that tests binding of biotherapeutics across the full human membrane and secreted proteome, expressed in unfixed cells.  What You'll Learn in Our Webinar: How Integral Molecular’s MPA rapidly and accurately identifies potential off-target binding liabilities  How MPA data support both lead selection and IND submissions with advantages over tissue cross-reactivity studies   How Cell-based protein arrays, like the MPA, are rapidly progressing towards FDA endorsement